Mitogenic activity of Epstein–Barr virus-encoded BARF1 protein
We previously reported that BARF1 gene has either an immortalizing effect, when expressed in primary primate epithelial cells, or a malignant transforming activity, when expressed in established and nontumoral rodent fibroblast or human B-cell lines. As predicted from sequence analysis, we found tha...
Gespeichert in:
Veröffentlicht in: | Oncogene 2004-06, Vol.23 (28), p.4938-4944 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We previously reported that
BARF1
gene has either an immortalizing effect, when expressed in primary primate epithelial cells, or a malignant transforming activity, when expressed in established and nontumoral rodent fibroblast or human B-cell lines. As predicted from sequence analysis, we found that
BARF1
coded protein can be secreted from different cell lines, among them
BARF1
-transfected Balb/c3T3 rodent fibroblasts. Thus, as an initial step to clarify
BARF1
oncogenic functions, we investigated whether the secreted form of
BARF1
protein can activate the cell cycle as a growth factor. Since efficient
BARF1
expression could be obtained from 293-tTA cells infected with a tetracycline-regulatable recombinant adenovirus, secreted
BARF1
product could be purified from the culture medium of such cells by ammonium sulfate precipitation, ion exchange chromotography and sucrose gradient sedimentation. We describe in this paper that addition of a purified product of secreted
BARF1
protein to serum-free culture medium of Balb/c3T3 rodent fibroblasts, human Louckes B-cell line and primary monkey kidney epithelial cells resulted in a cell cycle activation that was inhibited by affinity-purified anti-
BARF1
antibody. Our demonstration of a specific stimulation of cell cycle
in vitro
by
BARF1
secreted product suggests that this EBV-encoded
BARF1
protein could act as a growth factor
in vivo
. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/sj.onc.1207607 |